Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...

Please be advised, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead. Thank you, Kevin. Good morning, everyone, ...

A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...

On today's call are Stephane Bancel, Chief Executive Officer; Jamey Mock, Chief Financial Officer; and Stephen Hoge, President. Before we begin, please note that this conference call will include ...

Stephen Hoge, President: Regarding Norovirus, GBS occurs in the background population, and we paused activities to prioritize patient safety. The FDA placed us on hold while reviewing our documents, ...

Stephen Hoge, M.D. President of Moderna said: “At Moderna, we are immensely proud of our new manufacturing facility and clinical laboratories in Oxfordshire and the significant and ongoing investment ...

Stephen Hoge is one of three kickers vying for the starting job at Kansas University. Hoge is battling with fellow red-shirt freshman Jacob Branstetter and junior-college transfer Grady Fowler.